News | October 03, 2014

Esaote Receives FDA Clearance for Portable MyLab Gamma Ultrasound System

Highly portable ultrasound delivers affordable, feature-rich performance for shared service imaging

Esaote Receives FDA Clearnce for Portable MyLab Gamma Ultrasound System

October 3, 2014 — Esaote North America announced that its new MyLab Gamma ultrasound system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for sale in the United States.

MyLab Gamma is a laptop-sized ultrasound system with lightweight portability and feature-rich applications that facilitate its use in a wide variety of clinical environments, from shared service to dedicated clinics and point-of-care.

“Today’s practices are under increasing pressure to deliver quality healthcare at an affordable cost,” said Larry Dentice, president and general manager of Esaote North America. “The portability and affordability of MyLab Gamma helps providers deliver excellent care wherever and whenever it’s needed."

It incorporates advanced clinical technologies to support comprehensive cardiac and vascular exams, including TEE (transesophogeal echo), strain, stress echo and other quantitative studies. With 3-D/4-D capability and a wide range of available probes, the system is also well suited to women’s health, general imaging and non-traditional point-of-care applications.

Ergonomically designed to be easy to use and reduce sonographer stress, MyLab Gamma can operate on battery power with fast boot times and rapid resume modes so it’s easy to transport and ready to use within seconds. The two onboard probe connectors can be expanded to four, with the optional cart, giving MyLab Gamma users access to a wide range of clinical utility and flexibility.

For more information: www.esaoteusa.com

Related Content

FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
360 Photos | Ultrasound Imaging | July 11, 2019
This 360 degree photo shows a basic, point-of-care cardiac echocardiogram being performed using a smartphone turned i
360 Photos | Ultrasound Imaging | July 09, 2019
A view of a mitral valve on a GE Healthcare Vivid E95 ...
360 Photos | Ultrasound Imaging | July 08, 2019
This is a 360 degree view of a live cardiac echo demonstration for the Siemens Healthineers Acuson SC2000...
3D Auto RV application image courtesy of Philips Healthcare

3D Auto RV application image courtesy of Philips Healthcare

Technology | Cardiovascular Ultrasound | July 02, 2019
Philips recently announced new advanced automation capabilities on its Epiq CVx and Epiq CVxi cardiac ultrasound...
Konica Minolta Healthcare Partners With DiA Imaging Analysis for AI-based Cardiac Ultrasound Analysis
News | Cardiovascular Ultrasound | July 02, 2019
DiA Imaging Analysis has partnered with Konica Minolta Healthcare Americas Inc. to expand analysis capabilities of...
The Acuson Sequoia with Deep Abdominal Transducer (DAX) scanning a 600 pound patient.

The Acuson Sequoia with Deep Abdominal Transducer (DAX) scanning a 600 pound patient.

Sponsored Content | Case Study | Ultrasound Imaging | July 01, 2019
“With our present technology, we often struggle with large patients,” said Richard G.
FDA Issues Final Guidance on Marketing Clearance of Diagnostic Ultrasound Systems and Transducers
News | Ultrasound Imaging | June 27, 2019
The U.S. Food and Drug Administration (FDA) issued the final guidance: Marketing Clearance of Diagnostic Ultrasound...
Bay Labs Announces New Echocardiography Guidance Software Data at ASE 2019 Scientific Sessions
News | Cardiovascular Ultrasound | June 20, 2019
Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational guidance software...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...